Novel Nicotine Products’ Potential in Harm Reduction Gets Appropriators’ Nod
This article was originally published in The Tan Sheet
In its report on the fiscal 2016 spending bill it approved for FDA and USDA, the Appropriation Committee says sustaining 2007 cut-off date is unfair to electronic cigarettes and other yet-regulated tobacco and nicotine products already available.
You may also be interested in...
FDA encourages disclosures at public hearings
‘Recipe For Disaster’ In Supplement Manufacturing? US DoJ Attorney Cooks Up Likely Causes
"You end up with a recipe for maybe there's adulterants in the product. Maybe the product wasn't manufactured according to the spec, so it's misbranded. Worse, there could be adulterants. In some of those ingredients, there's a lot of potential failures,” says Patrick Runkle, senior litigation counsel at DoJ Consumer Protection Branch, during FDL conference.
US FDA Supplement Facility Inspection Numbers Back To Typical Along With GMP Problems Found
Supplement facility GMP inspections by FDA in 2022 along with the frequency of form 483s sent to firms following inspections return to roughly pre-pandemic annual numbers after dipping during 2020 and 2021.